Alex received his BSc in Biochemistry from the University of Kent at Canterbury in 1990 and his PhD from the MRC Laboratory of Molecular Biology, Cambridge in 1994. He carried out postdoctoral research at the Whitehead Institute for Biomedical Research in Cambridge, MA, USA, and the University of York. In 2002, he moved to the National Physical Laboratory where he was a Principal Research Scientist in the Biotechnology Group.
Alex is intrigued by the potential of microbiomics and related fields of science to unlock new insights into individual health and well-being. The challenges of turning the large, complex data sets produced by modern bioscience into clear insights that consumers can use are fascinating, and will require a combination of statistical, bioinformatic, machine learning and related approaches.
Graduating from Mysore University, India in 1981, Shervanthi Homer-Vanniasinkam became a Fellow of the Royal College of Surgeons of Edinburgh in 1989 and a Fellow of the Royal College of Surgeons of England in 1998. She was appointed Consultant Vascular Surgeon at Leeds General Infirmary in 1995, a post she continues to hold. She is also Clinical Sub-Dean, University of Leeds Medical School and Director of EXSEL@Leeds; Founding Professor of Surgery, University of Warwick Medical School & University Hospitals Coventry and Warwickshire, and Professor of Engineering and Surgery, University College London. Shervanthi has published 127 papers and book chapters and has given over 300 invited presentations worldwide. She is also a non-executive director at Tissue Regenix and serves on many committees and advisory boards.
Louise is also Chief Executive Officer of Complement Genomics and is a post graduate in Medical Genetics, having carried our research into the genetics of colon cancer. Louise’s focus is on the company’s quality systems.
Neil has been involved in genetic testing and molecular biology for over 30 years and is the author of over 40 original publications and three books. His current role in the company is in new business development and marketing.